Most 70- to 79-year-old patients with acute myeloid leukemia do benefit from intensive treatment

To the editor: Kantarjian and coworkers have recently stated that intensive chemotherapy does not benefit most older patients with acute myeloid leukemia (AML),[1][1] in contrast to the Swedish published experience.[2][2] Their view was based on 446 patients 70 years or older who were referred to